Literature DB >> 26873619

The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition.

Naruto Taira1, Masami Arai2, Masahiko Ikeda3, Motoki Iwasaki4, Hitoshi Okamura5, Kiyoshi Takamatsu6, Tsunehisa Nomura7, Seiichiro Yamamoto8, Yoshinori Ito9, Hirofumi Mukai10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26873619     DOI： 10.1007/s12282-016-0673-8

Source DB:  PubMed          Journal:  Breast Cancer        ISSN： 1340-6868            Impact factor:   4.239


× No keyword cloud information.
  5 in total

1.  Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.

Authors:  Yutaro Otsuka; Tsukasa Oikawa; Hinako Yoshino; Shigeru Hashimoto; Haruka Handa; Hiroki Yamamoto; Ari Hashimoto; Hisataka Sabe
Journal:  Cell Commun Signal       Date:  2018-01-05       Impact factor: 5.712

Review 2.  A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer.

Authors:  Carol Forbes; Debra Fayter; Shelley de Kock; Ruben Gw Quek
Journal:  Cancer Manag Res       Date:  2019-03-22       Impact factor: 3.989

3.  Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.

Authors:  Satoko Shimada; Reiko Yoshida; Eri Nakashima; Dai Kitagawa; Naoya Gomi; Rie Horii; Sayoko Takeuchi; Yuumi Ashihara; Mizuho Kita; Futoshi Akiyama; Shinji Ohno; Mitsue Saito; Masami Arai
Journal:  Breast Cancer       Date:  2019-04-12       Impact factor: 4.239

4.  Persistent homology index as a robust quantitative measure of immunohistochemical scoring.

Authors:  Akihiro Takiyama; Takashi Teramoto; Hiroaki Suzuki; Katsushige Yamashiro; Shinya Tanaka
Journal:  Sci Rep       Date:  2017-10-25       Impact factor: 4.379

5.  Genetic and clinical characteristics in Japanese hereditary breast and ovarian cancer: first report after establishment of HBOC registration system in Japan.

Authors:  Masami Arai; Shiro Yokoyama; Chie Watanabe; Reiko Yoshida; Mizuho Kita; Megumi Okawa; Akihiro Sakurai; Masayuki Sekine; Junko Yotsumoto; Hiroyuki Nomura; Yoshinori Akama; Mayuko Inuzuka; Tadashi Nomizu; Takayuki Enomoto; Seigo Nakamura
Journal:  J Hum Genet       Date:  2017-11-08       Impact factor: 3.172
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.